Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

203 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Autoimmune and angiogenic biomarkers in autoimmune atherosclerosis.
Balogh E, Pusztai A, Hamar A, Végh E, Szamosi S, Kerekes G, McCormick J, Biniecka M, Szántó S, Szűcs G, Nagy Z, Fearon U, Veale DJ, Szekanecz Z. Balogh E, et al. Among authors: pusztai a. Clin Immunol. 2019 Feb;199:47-51. doi: 10.1016/j.clim.2018.12.011. Epub 2018 Dec 10. Clin Immunol. 2019. PMID: 30543922 Review.
Vitamin D status in men with psoriatic arthritis: a case-control study.
Petho Z, Kulcsar-Jakab E, Kalina E, Balogh A, Pusztai A, Gulyas K, Horvath A, Szekanecz Z, Bhattoa HP. Petho Z, et al. Among authors: pusztai a. Osteoporos Int. 2015 Jul;26(7):1965-70. doi: 10.1007/s00198-015-3069-2. Epub 2015 Feb 19. Osteoporos Int. 2015. PMID: 25693749
Gene expression analysis of vascular pathophysiology related to anti-TNF treatment in rheumatoid arthritis.
Póliska S, Besenyei T, Végh E, Hamar A, Pusztai A, Váncsa A, Bodnár N, Szamosi S, Csumita M, Kerekes G, Szabó Z, Nagy Z, Szűcs G, Szántó S, Zahuczky G, Nagy L, Szekanecz Z. Póliska S, et al. Among authors: pusztai a. Arthritis Res Ther. 2019 Apr 15;21(1):94. doi: 10.1186/s13075-019-1862-6. Arthritis Res Ther. 2019. PMID: 30987671 Free PMC article.
Effects of 1-year anti-TNF-α therapies on bone mineral density and bone biomarkers in rheumatoid arthritis and ankylosing spondylitis.
Gulyás K, Horváth Á, Végh E, Pusztai A, Szentpétery Á, Pethö Z, Váncsa A, Bodnár N, Csomor P, Hamar A, Bodoki L, Bhattoa HP, Juhász B, Nagy Z, Hodosi K, Karosi T, FitzGerald O, Szücs G, Szekanecz Z, Szamosi S, Szántó S. Gulyás K, et al. Among authors: pusztai a. Clin Rheumatol. 2020 Jan;39(1):167-175. doi: 10.1007/s10067-019-04771-3. Epub 2019 Sep 14. Clin Rheumatol. 2020. PMID: 31522318
Complex assessment of bone mineral density, fracture risk, vitamin D status, and bone metabolism in Hungarian systemic sclerosis patients.
Horváth Á, Végh E, Pusztai A, Pethő Z, Hamar A, Czókolyová M, Bhattoa HP, Nagy G, Juhász B, Hodosi K, Domján A, Szekanecz Z, Szücs G, Szamosi S. Horváth Á, et al. Among authors: pusztai a. Arthritis Res Ther. 2019 Dec 10;21(1):274. doi: 10.1186/s13075-019-2072-y. Arthritis Res Ther. 2019. PMID: 31823821 Free PMC article.
Soluble Vascular Biomarkers in Rheumatoid Arthritis and Ankylosing Spondylitis: Effects of 1-year Antitumor Necrosis Factor-α Therapy.
Pusztai A, Hamar A, Horváth Á, Gulyás K, Végh E, Bodnár N, Kerekes G, Czókolyová M, Szamosi S, Bodoki L, Hodosi K, Domján A, Nagy G, Szöllősi I, Lopez LR, Matsuura E, Prohászka Z, Szántó S, Nagy Z, Shoenfeld Y, Szekanecz Z, Szűcs G. Pusztai A, et al. J Rheumatol. 2021 Jun;48(6):821-828. doi: 10.3899/jrheum.200916. Epub 2020 Dec 15. J Rheumatol. 2021. PMID: 33323530
Effects of one-year tofacitinib therapy on bone metabolism in rheumatoid arthritis.
Hamar A, Szekanecz Z, Pusztai A, Czókolyová M, Végh E, Pethő Z, Bodnár N, Gulyás K, Horváth Á, Soós B, Bodoki L, Bhattoa HP, Nagy G, Tajti G, Panyi G, Szekanecz É, Domján A, Hodosi K, Szántó S, Szűcs G, Szamosi S. Hamar A, et al. Among authors: pusztai a. Osteoporos Int. 2021 Aug;32(8):1621-1629. doi: 10.1007/s00198-021-05871-0. Epub 2021 Feb 9. Osteoporos Int. 2021. PMID: 33559714 Free PMC article.
203 results